“…(see also van Oers, 2011). These approaches are more widely known as baculovirus display technology constituting a eukaryotic display platform for a wide range of applications such as drug discovery, vaccination or targeted gene therapy (Grabherr and Ernst, 2010;Hu et al, 2008;Kaikkonen et al, 2008;Raty et al, 2004). The most widely used technique for surface engineering makes use of the trimeric major baculoviral envelope glycoprotein GP64 as a fusion partner (Kadlec et al, 2008).…”